000 01785 a2200541 4500
005 20250515053827.0
264 0 _c20070322
008 200703s 0 0 eng d
022 _a1354-523X
024 7 _a10.1111/j.1601-0825.2006.01252.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAframian, D J
245 0 0 _aPilocarpine treatment in a mixed cohort of xerostomic patients.
_h[electronic resource]
260 _bOral diseases
_cJan 2007
300 _a88-92 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aBody Temperature
_xdrug effects
650 0 4 _aCohort Studies
650 0 4 _aDizziness
_xchemically induced
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscarinic Agonists
_xadministration & dosage
650 0 4 _aPilocarpine
_xadministration & dosage
650 0 4 _aRadiotherapy
_xadverse effects
650 0 4 _aSaliva
_xdrug effects
650 0 4 _aSecretory Rate
_xdrug effects
650 0 4 _aSialadenitis
_xcomplications
650 0 4 _aSjogren's Syndrome
_xcomplications
650 0 4 _aSweating
_xdrug effects
650 0 4 _aUrination
_xdrug effects
650 0 4 _aXerostomia
_xdrug therapy
700 1 _aHelcer, M
700 1 _aLivni, D
700 1 _aRobinson, S D M
700 1 _aMarkitziu, A
700 1 _aNadler, C
773 0 _tOral diseases
_gvol. 13
_gno. 1
_gp. 88-92
856 4 0 _uhttps://doi.org/10.1111/j.1601-0825.2006.01252.x
_zAvailable from publisher's website
999 _c16804830
_d16804830